Expert Review of Vaccines

Influenza A/H1N1 in 2009: a pandemic in evolution
pp. 819-822(4)
Authors: Clark, Tristan; Stephenson, Iain

Challenge of developing new tuberculosis vaccines to generate life-long protective immunity
pp. 823-825(3)
Authors: Triccas, James A; Nambiar, Jonathan K

News in brief
pp. 827-829(3)

Pediatric combined formulation DTaP-IPV/Hib vaccine
pp. 831-840(10)
Authors: White, Craig; Halperin, Scott A; Scheifele, David W

The new ACAM2000™ vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks
pp. 841-850(10)
Authors: Handley, Lauren; Buller, Robert Mark; Frey, Sharon E; Bellone, Clifford; Parker, Scott

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
pp. 851-861(11)
Authors: Trotter, Caroline L; Maiden, Martin CJ

Bordetella pertussis strain variation and evolution postvaccination
pp. 863-875(13)
Authors: Kallonen, Teemu; He, Qiushui

Rationally designed tularemia vaccines
pp. 877-885(9)
Authors: Mann, Barbara J; Ark, Nicole M

SARS vaccines: where are we?
pp. 887-898(12)
Authors: Roper, Rachel L; Rehm, Kristina E

Economic evaluations of hepatitis B vaccination for developing countries
pp. 907-920(14)
Authors: Tu, Hong-Anh T; Woerdenbag, Herman J; Kane, Sumit; Riewpaiboon, Arthorn; van Hulst, Marinus; Postma, Maarten J

Vaccination approaches against Trypanosoma cruzi infection
pp. 921-935(15)
Authors: Cazorla, Silvia Inés; Frank, Fernanda María; Malchiodi, Emilio Luis

Chitosan-based systems for the delivery of vaccine antigens
pp. 937-953(17)
Authors: Arca, H. Çiğdem; Günbeyaz, Merve; Şenel, Sevda

Acknowledgements
pp. 961-961(1)